Liquid chromatography-tandem mass spectrometry applications in endocrinology

Mass Spectrometry Reviews

Volumn 29, Issue 3, 2010, Pages 480-502

  Kushnir, Mark M ^a,b   Rockwood, Alan L ^a,c   Bergquist, Jonas ^b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Clinical; Derivatization; Quantitation; Sample preparation; Specificity; Steroids; Tandem mass spectrometry

Indexed keywords

ACCURATE ANALYSIS; ANALYTICAL METHOD; ANALYTICAL TECHNIQUES; BIOLOGICAL SAMPLES; CLINICAL UTILITY; DERIVATIZATIONS; ENDOGENOUS STEROIDS; EPIDEMIOLOGICAL STUDIES; HIGH SPECIFICITY; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; METABOLIC DISEASE; MULTIPLE ANALYTES; OVARIAN FOLLICLES; QUANTITATION; SAMPLE PREPARATION; TANDEM MASS SPECTROMETRY;

DIAGNOSIS; ENDOCRINOLOGY; HORMONES; LIPIDS; LIQUIDS; MASS SPECTROMETRY;

LIQUID CHROMATOGRAPHY;

BIOLOGICAL MARKER; STEROID;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ENDOCRINOLOGY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; OVARY; QUALITY CONTROL; TANDEM MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ENDOCRINOLOGY; FEMALE; HUMANS; OVARY; QUALITY CONTROL; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 77952801705     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.20264     Document Type: Article

References (159)

1. Alary JF. 2001. Comparative study: LC/MS/MS analysis of four steroid compounds using a new photoionization source and a conventional APCI source. Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics, Chicago, 2001; Paper TP009.
2. Alström T, Gräsbeck R, Lindblad B, Solberg HE, Winkel. P, Viinikka L. 1993. Establishing reference values from adults: Recommendation on procedures for the preparation of individuals, collection of blood, and handling and storage of specimens. Committee on Reference Values of the Scandinavian Society for Clinical Chemistry. Scand J Clin Lab Invest 5:649-652.
3. Altman DG, Bland JM. 1983. Measurement in medicine: The analysis of method comparison studies. Statistician 32:307-317.
4. Anari MR, Bakhtiar R, Zhu B, Huskey S, Franklin RB, Evans DC. 2002. Derealization of ethinylestradiol with dansyl chloride to enhance electrospray ionization: Application in trace analysis of ethinylestradiol in rhesus monkey plasma. Anal Chem 74:4136-4144. (Pubitemid 34912914)
5. Andersen CY. 1993. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 77:1227-1234.
6. Anderson JL, Carlquist JF, Roberts WL, Home BD, May HT, Schwarz EL, Pasquali M, Nielson R, Kushnir MM, Rockwood AL, Bair TL, Muhlestein JB, for the Intermountain Heart Collaborative (IHC) Study Group. 2007. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: Markers for diabetes and cardiovascular risk? Am Heart J 153:67-73.
7. Andrews RC, Walker BR. 1999. Glucocorticoids and insulin resistance: Old hormones, new targets. Clin Sci 96:513-523.
8. Annesley TM. 2003. Ion suppression in mass spectrometry. Clin Chem 49:1041-1044.
9. Annesley TM. 2007. Methanol-associated matrix effects in electrospray ionization tandem, mass spectrometry. Clin Chem. 53:1827-1834. (Pubitemid 47509677)
10. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. 2000. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438. (Pubitemid 32269197)
11. Barcelo D, Hennion MC. 1997. On-line sample strategies. In: Trace determination of pesticides and their degradation products in water. Amsterdam, NL: Elsevier, pp. 357-422.
12. Beck JR, Shultz EK. 1986. The use of receiver operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 110:13-20.
13. Berzelius JJ. 1812. General, views of the composition of animal fluids. Med Chir Trans 3:198-276.
14. Biomarkers Definitions Working Group. 2001. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework, Clin Pharmacol Ther 69:89-95.
15. Bonfiglio R, King RC, Olah TV, Merkle K. 1999. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom. 13:1175-1185. (Pubitemid 29285118)
16. Borrey D, Moerman E, Cockx A, Engelrelst V, Langlois MR. 2007. Columnswitching LC-MS/MS analysis for quantitative determination of testosterone in human serum. Clin Chim Acta 382:134-137. (Pubitemid 46782732)
17. Bruins AP, Covey TR, Henion JD. 1987. Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometry. Anal Chem. 59:2642-2646. (Pubitemid 18530994)
18. Busch KL, Glish GL, McLuckey SA. 1988. Mass spectrometry/mass spectrometry: Techniques and applications of tandem mass spectrometry. New York: VCH Publishers, Inc.
19. Carel JC, Léger J. 2008. Precocious puberty. N Engl. J Med 358:2366-2377.
20. Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, Barth JH. 2005. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: Validation of a method for routine clinical practice. Clin Chem 51:1472-1479. (Pubitemid 41060880)
21. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. 1993. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39:66-71. (Pubitemid 23034958)
22. Choi HH, Gray PB, Storer TW, Calof OM, Woodhouse L, Singh AB, Padero C, Kushnir MM, Rockwood AL, Meikle AW, Mac RP, SinhaHikim I, Shen R, Dzekov J, Dzekov C, Lee M, Hays RD, Bhasin S. 2005. Effects of testosterone replacement in human immunodeficiency virusinfected women with weight loss. J Clin Endocrinol Metab 90:1531-1541. (Pubitemid 40464015)
23. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW. 1992. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 37:127-134.
24. Coodley GO, Coodley MK. 1997. A trial of testosterone therapy for HIV associated weight loss. AIDS 11:1347-1352.
25. Cooks RG. 1995. Collision-induced dissociation: Readings and commentary. J Mass Spectrom 30:1215-1221.
26. Combleet PJ, Gochman N. 1979. Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 25:432-438. (Pubitemid 9142871)
27. Cover Story. 2008. New testosterone assays may become gold standard. Endocr Today 6(2): 1, 12-14.
28. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. 1992. Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model, based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604. (Pubitemid 23050339)
29. De Sutter P, Dhont M, Vanluchene E, Vandekerckhove E. 1991, Correlation between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization. Fértil Steril 55:958-963.
30. Dehennin L. 1990. Estrogens, androgens, and progestins in follicular fluid from preovulatory follicles: Identification and quantification by gas chromatography/mass spectrometry associated with stable isotope dilution. Steroids 55:181-184 (review). (Pubitemid 20270443)
31. Dehennin L, Jondet M, Scholler R. 1987a. Androgen and 19-norsteroid profiles in human preovulatory follicles from stimulated cycles: An isotope dilution-mass spectrometric study. J Steroid Bioehem 26:399-405. (Pubitemid 17066084)
32. Dehennin L, Nahoul K, Scholler R. 1987b. Steroid 21-hydroxylation by human preovulatory follicles from stimulated cycles: A mass spectrometrical study of deoxycorticosterone, 21-hydroxypregnenolone and 11-deoxyCortisol in follicular fluid. J Steroid Biochem. 26:337-343. (Pubitemid 17066076)
33. Dharan M, 1977. Total quality control in the clinical laboratory. St. Louis: The CV. Mosby Company.
34. Dubey RK, Jackson EK. 2001. Genome and hormones: Gender differences in physiology. Invited review: Cardiovascular protective effects of 17betaestradiol metabolites. J Appl Physiol 91:1868-1883.
35. Edwards CRW, Walker BR, Benediktsson R, Seckl JR. 1983. Congenital and acquired syndrome of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol 45:1-5.
36. Franks S. 1995. Polycystic ovary syndrome. N Engl J Med 333:853-861.
37. Gao S, Zhang ZP, Karnes HT. 2005. Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives. J Chromatogr B 825:98-110. (Pubitemid 41423593)
38. Giddings JC. 1987. Concepts and comparisons in multidimensional separation. J High Resol Chromatogr Commun 10:319-323.
39. Goderie-Plomp HW, van der Klift M, de Ronde W, Hofman A, de Jong FH, Pols HA. 2004. Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: The Rotterdam Study. J Clin Endocrinol Metab 89:3261-3269. (Pubitemid 38951891)
40. Gräsbeck R. 2004. The evolution of the reference value concept. Clin Chem. Lab Med 42:692-697.
41. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: Potential mechanisms of action. Int J Dev Neurosci 18:347-358. (Pubitemid 30243066)
42. Greenwald GS, Roy SK. 1994. Follicular development and its control. In: Knobil E, Neill JD, editors. The physiology of reproduction. 2nd edition. New York: Raven Press, pp. 629-724.
43. Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A. 1997. Body composition and endocrine function in women with, acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 82:1332-1337. (Pubitemid 27200397)
44. Grumbach MM, Hughes I, Conte FA. 2002. Disorders of sexual differentiation. In: Larsen PR, Kronenberg HM, Melmed S, Polansky KS, editors. Williams textbook of endocrinology. 10th edition. New York: Saunders, pp. 842-1002.
45. Guo T, Taylor RL, Singh RJ, Soldin SJ. 2006. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem, mass spectrometry. Clin Chim Acta 372:76-82. (Pubitemid 44286760)
46. Guo T, Gu J, Soldin OP, Singh RJ, Soldin SJ. 2008. Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin Biochem. 41:736-741.
47. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigen FJ, Luppa PB, Nykjaer A, Willnow TE. 2005. Role of endocytosis in cellular uptake of sex steroids. Cell 122:751-762. (Pubitemid 41242639)
48. Hanold KA, Fischer SM, Cormia PH, Miller CE, Syage JA. 2004. Atmospheric pressure photoionization. 1. General, properties for LC/ MS. Anal Chem. 76:2842-2851.
49. Haymond S, Gronowski AM. 2005. Reproductive related disease. In: Ashwood ER, Burtis CA, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New York: Saunders. pp. 2097-2152.
50. Herold DA, Fitzgerald RL. 2003. Immunoassays for testosterone in women: Better than a guess? Clin Chem 49:1250-1251.
51. Higashi T, Shimada K. 2004. Derivatization of neutral steroids to enhance their detection characteristics in liquid chromatography-spectrometry. Anal Bioanal Chem 378:875-882. (Pubitemid 40890200)
52. http://www.mayo.edu/mshs/lab-career.html (accessed February 5, 2008). Laboratory Sciences Career Overview.
53. http://www.westgard.com/biodatabasel,htm (accessed February 5, 2008). Desirable specifications for total, error, imprecision, and bias, derived from biologic variation.
54. Higashi T, Awada D, Shimada K. 2001, Simultaneous determination of 25-hydroxyvltamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with, a Cookson-type reagent. Biol Pharm Bull 24:738-743. (Pubitemid 32633478)
55. Itskovitz J, Rubattu S, Rosenwaks Z, Liu HC, Sealey JE. 1991. Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization. J Clin Endocrinol Metab 72:165-171.
56. Iughetti L, Predieri B, Ferrari M, Gallo C, Livio L, Milioli S, Forese S, Bernasconi S. 2000. Diagnosis of central precocious puberty: Endocrine assessment. J Pediatr Endocrinol Metab 13:709-715.
57. Johnson DW. 1999. Dimethylaminoethyl esters for trace, rapid analysis of fatty acids by electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 13:2388-2393.
58. Johnson DW. 2001. Analysis of amino acids as formamidene butyl esters by electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 15:2198-2205.
59. Johnson DW, ten Brink HJ, Jakobs C. 2001, A rapid screening procedure for cholesterol and dehydrocholesterol by electrospray ionization tandem mass spectrometry. J Lipid Res 42:1699-1705.
60. Kahn SM, Li YH, Hryb DJ, Nakhla AM, Romas NA, Cheong J, Rosner W. 2008. Sex hormone-binding globulin influences gene expression of LNCaP and MCF-7 cells in response to androgen and estrogen treatment. Adv Exp Med Biol 617:557-564.
61. Kanu AB, Dwivedi P, Tam M, Matz L, Hill HH, Jr. 2008. Ion mobility-mass spectrometry. J Mass Spectrom 43:1-22.
62. Kaufmann A, Butcher P. 2005. Segmented post-column analyte addition; a concept for continuous response control of liquid chromatography/mass spectrometry peaks affected by signal suppression/enhancement. Rapid Commun Mass Spectrom 19:611-617.
63. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. 2000. Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom 11:942-950.
64. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB Jr. 1994. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94:2475-2480.
65. Kol S. 2003. Hormonal therapy of the infertile women. In: Meikle AW, editor. Endocrine replacement therapy in clinical practice. New Jersey: Humana. pp. 525-537.
66. Kong A, Edmonds P. 2002. Testosterone therapy in HIV wasting syndrome: Systematic review and meta-analysis. Lancet Infect Dis 2:692-699.
67. Koskinen P, Penttila TA, Anttila L, Erkkola R, Irjala K. 1996. Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 65:517-522.
68. Kushnir MM, Crockett DK, Nelson G, Urry FM. 1999. Comparison of four derivatizing reagents for 6-acetylmorphine GC-MS analysis. J Anal Toxicol 23:262-269.
69. Kushnir MM, Komaromy-Hiller G, Shushan B, Urry FM, Roberts WL. 2001. Analysis of dicarboxylic acids by tandem mass spectrometry. High throughput quantitative measurement of methylmalonic acid in serum, plasma and urine. Clin Chem 47:1993-2002.
70. Kushnir MM, Shushan B, Roberts WL, Pasquali M. 2002. Acylcarnitines and vitamin B12 deficiency. Clin Chem 48(7):1126-1128.
71. Kushnir MM, Rockwood AL, Nelson GJ, Terry A, Meikle AW. 2003. Analysis of cortisol in urine by LC-MS/MS. Clin Chem 49:965-967.
72. Kushnir MM, Rockwood AL, Nelson GJ. 2004. Simultaneous quantitative analysis of isobars by tandem mass spectrometry from unresolved chromatographic peaks. J Mass Spectrom 39:532-540.
73. Kushnir MM, Nielsen R, Roberts WL, Rockwood AL. 2004. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Clin Biochem 37:357-362.
74. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. 2005. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem 38:319-327.
75. Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Bunker AM, Fitzgerald RL, Meikle AW. 2006a. Performance characteristics of a novel tandem mass spectrometry assay for analysis of testosterone in serum. Clin Chem 52:120-128.
76. Kushnir MM, Rockwood AL, Roberts WL, Owen WE, Bunker AM, Meikle AW. 2006b. Development and performance evaluation of a tandem mass spectrometry assay for four adrenal steroids. Clin Chem 52:1559-1567.
77. Kushnir MM, Rockwood AL, Roberts WL, Bergquist J, Varshavsky M, Yue B, Bunker AM, Meikle AW. 2007. High sensitivity tandem mass spectrometry test for serum estrogens. Clin Chem 53:A183.
78. Kushnir MM, Rockwood AL, Bergquist J, Varshavsky M, Roberts WL, Yue B, Bunker AM, Meikle AW. 2008. High sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol 129:530-539.
79. Kushnir MM, Naessen T, Kirilovas D, Chaika A, Nosenko J, Mogilevkina I, Rockwood AL, Carlstrom K, Bergquist J. 2009. Steroid profiles in ovarian follicular fluid samples using high sensitivity tandem mass spectrometry methods. Clin Chem 55:519-526.
80. Lacey JM, Minutti1 CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern1 D. 2004. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. 50:621-625.
81. Lacorte S, Vreuls JJ, Salau JS, Ventura F, Barcelo D. 1998. Monitoring of pesticides in river water using fully automated on-line SPE and LC with DAD with a novel filtration device. J Chromatogr A 795:71-82.
82. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. 2005. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 38:404-415.
83. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR. 2006. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 91:3791-3797.
84. Legro RS, Driscoll D, Strauss JF III, Fox J, Dunaif A. 1998. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95:14956-14960.
85. Leung YS, Dees K, Cyr R, Schloegel I, Kao PC. 1997. Falsely increased serum, estradiol results reported in direct estradiol assays. Clin Chem 43:1250-1251.
86. Linnet K. 1987. Two-stage transformation systems for normalization of reference distributions evaluated. Clin Chem 33:381-386.
87. Luppa P, Müller B, Jacob K, Kimmig R, Strowitzki T, Höss C, Weber MM, Engelhardt D, Lobo RA. 1995. Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: Evidence for an altered corticoid excretion. J Clin Endocrinol Metab 80:280-288.
88. Ly LP, Handelsman DJ. 2005. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 152:471-478.
89. Matsumoto AM, Bremner WJ. 2004. Serum testosterone assays - Accuracy matters. J Clin Endocrinol Metab 89:520-524.
90. Matuszewski BK, Constanzer ML, Chavez-Eng CM. 2003. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019-3030.
91. McLuckey SA. 1992. Principles of collisional activation in analytical mass spectrometry. J Am. Soc Mass Spectrom 3:599-614.
92. McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ. 1979. The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49:851-860.
93. Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL, Meikle AW, Jacqueline R, Center JA, Eisman JA, Seibel MJ. 2008. Endogenous sex hormones and incident fracture risk in older men: The Dubbo osteoporosis epidemiology study. Arch Intern Med 168: 47-54.
94. Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH. 2003. Pseudocushings syndrome cause by interference of drug fenofibrate with HPLC assay for cortisol. J Clin Endocrinol Metab 88:3521-3524.
95. Meikle AW, Kushnir MM, Rockwood AL, Pattison EG, Terry AH, Sandrock T, Bunker AM, Phanslkar AR, Owen WE, Roberts WL. 2007. Adrenal steroid concentrations in children seven to seventeen years of age. J Pediatr Endocrinol Metab 20:1281-1291.
96. Mellström D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C. 2006. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men. J Bone Miner Res 21:529-535.
97. Miller WL. 1988. Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318.
98. Miller JW, Garrod MG, Rockwood AL, Kushnir MM, Allen LH, Haan MN, Green R. 2006. Holotranscobalamin II measurement improves the predictive value of total plasma B12 in screening for B12 deficiency. Clin Chem 52:278-285.
99. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F. 1989. Application of fast atom, bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem 180:331-339.
100. Moran C, Potter HD, Reyna R. 1999. Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperan-drogenic women with adrenal androgen excess. Am J Obstet Gynecol 181:596-600.
101. Morr MK, Wagner AD, Patel M, et al. 2006. Quantitative LC-MS/MS analysis of endogenous biomarkers for clinical diagnosis in endocrinology. Proceedings of the 54th ASMS Conference on Mass Spectrometry, Allied Topics, Seattle; Paper TP14.
102. Naessen T, Rodriguez-Macias K. 2006. Menopausal estrogen therapy counteracts normal aging effects on intima thickness, media thickness and intima/media ratio in carotid and femoral arteries. An investigation using noninvasive high-frequency ultrasound. Atherosclerosis 189: 387-392.
103. Naessen T, Persson I, Ljunghall S, Bergstrom R. 1992. Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis. Osteoporos Int 2:225-231.
104. Napoli N, Donepudi S, Sheikh S, Rini GB, Armamento-Villareal R. 2005. Increased 2-hydroxylation of estrogen in women with a family history of osteoporosis. J Clin Endocrinol Metab 90:2035-2041.
105. Nelson RE, Grebe SK, O'Kane DJ, Singh RJ. 2004. Liquid chromatographytandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 50:373-384.
106. Norjavaara E, Ankarberg C, Albertsson-Wikland K. 1996. Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: Evaluation by a sensitive radioimmunoassay. J Clin Endocrinol Metab 81:4095-4102.
107. Novak TJ, Yuan H. 2000. The determination of a chlorinated benzofuran pharmaceutical intermediate by HPLC-MS with on-line derivatization. J Pharm Biomed Anal 23:705-713.
108. Pang S. 2001. Congenital adrenal hyperplasia owing to 3 beta-hydroxysteroid dehydrogenase deficiency. Endocrinol Metab Clin North Am 30: 81-99.
109. Passing H, Bablok W. 1983. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I. J Clin Chem Clin Biochem 21:709-720.
110. Paul W, Steinwedel H. 1953. A new mass spectrometer without a magnetic field. Z .Naturforsch 8:448-450.
111. Payne AH, Hales DB. 2004. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947-970.
112. Plebani M. 2006. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 44:750-759.
113. Plebani M, Carraro P. 1997. Mistakes in a stat laboratory: Types and frequency. Clin Chem 43:1348-1351.
114. Reinke M. 2000. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56.
115. Rhoads RA, Friedberg F. 1993. Affinity chromatography of enzymes. In: Kline T, editor. Handbook of affinity chromatography. New York: Marcel Dekker, Inc. pp. 79-111.
116. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. 1999. Current databases on biologic variation: Pros, cons and progress. Scand J Clin Lab Invest 59:491-500.
117. Ritchie RF, Palomaki G. 2004. Selection of clinically relevant populations for reference ranges. Clin Chem Lab Med 42:702-709.
118. Robb DB, Covey TR, Bruins AP. 2000. Atmospheric pressure photoionization: An ionization method for liquid chromatography-mass spectrometry. Anal Chem 72:3653-3659.
119. Roberts WL, McMillin GA, Burtis CA, Bruns DE. 2005. Reference information for clinical laboratory. In: Ashwood ER, Burtis CA, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New York: Saunders, pp. 2251-2318.
120. Rosenfeld L. 2002. Clinical chemistry since 1800: Growth and development. Clin Chem 48:186-197.
121. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. 2007. Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement. J Clin Endocrinol Metab 92:405-413.
122. Sahab ZJ, Semaan SM, Sang QX. 2007. Methodology and applications of disease biomarker identification in human serum. Biomarker Insights 2:21-43.
123. Shultz EK, Aliferis C, Aronsky D. 2005. Clinical evaluation of methods. In: Ashwood ER, Burtis CA, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New York: Saunders. pp. 409-424.
124. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. 2005. Reproductive hormone reference intervals for healthy fertile young men: Evaluation of automated platform assays. J Clin Endocrinol Metab 90:5928-5936.
125. Singh G, Gutierrez A, Xu K, Blair IA. 2000. Liquid chromatography/ electron capture atmospheric pressure chemical ionization/mass spectrometry: Analysis of pentafluorobenzyl derivatives of biomolecules and drugs in the attomole range. Anal Chem 72:3007-3013.
126. Singh AB, Lee ML, Sinha-Hikim I, Kushnir MM, Meikle AW, Rockwood AL, Afework S, Bhasin S. 2006. Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab 91:136-144.
127. Singh M, Dykens JA, Simpkins JW. 2006. Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med 231:514-521.
128. Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S. 1998. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 83:1312-1318.
129. Sinicco A, Raiteri R, Rossati A, Savarino A, Di Perri G. 2000. Efavirenz interference in estradiol ELISA assay. Clin Chem 46:734-735.
130. Smitz J, Andersen AN, Devroey P, Arce J-C, The MERIT Group. 2007. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 22:676-687.
131. Solberg HE. 2004. The IFCC recommendation on estimation of reference intervals. Clin Chem Lab Med 42:710-714.
132. Solberg HE. 2005. Establishment and use of reference values. In: Ashwood ER, Burtis CA, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New York: Saunders, pp. 425-448.
133. Speiser PW. 2004. Improving neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3685-3686.
134. Speroff L, Glass RH, Kase NG. 1999. Chapter 6: Regulation of the menstrual cycle. In: Mitchell C, editor. Clinical gynecologic endocrinology and infertility. 6th edition. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 202-246.
135. Stanczyk FZ, Lee JS, Santen RJ. 2007. Standardization of steroid hormone assays: Why, how, and when? Cancer Epidemiol Biomarkers Prev 16:1713-1719.
136. Stein IF, Leventhal ML. 1935. Amenorrhea associated with bilateral polycystic ovaries. Am. J Obstet Gynecol 29:181.
137. Stewart PM. 1996. 11β-Hydroxysteroid dehydrogenase: Implications for clinical medicine. Clin Endocrinol (Oxf) 44:493-499.
138. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CHL. 1999. Cortisol metabolism in human obesity: Impaired cortisone to cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027.
139. Summers RH, Herold DA, Seely BL. 1996. Hormonal and genetic analysis of a patient with congenital adrenal hyperplasia. Clin Chem 42:1483-1487.
140. Taieb J, Benattar C, Birr AS, Lindenbaum A. 2002. Limitations of steroid determination by direct immunoassay. Clin Chem 48:583-585.
141. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C, Boudou P. 2003. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem 49:1381-1395.
142. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L. 1995. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vase Biol 15:821-826.
143. Taylor RL, Machacek D, Singh RJ. 2002. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 48:1511-1519.
144. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19:41-47.
145. Thienpont LM, Van Uytfanghe K, Stockl D, Blincko S, Ramsay CS, Xie H, Doss RC, Keevil BG, Owen LJ, Rockwood AL, Kushnir MM, Chun KY, Chandler DW, Field HP, Sluss PM. 2008. State-of-theart of serum testosterone measurement by isotope dilution-liquid chromatography/tandem mass spectrometry. Clin Chem 54:1290-1297.
146. Turhan NO, Toppare MF, Seckin NC, Dilmen G. 1999. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea. Gynecol Obstet Invest 48:183-186.
147. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF III, Spielman RS, Dunaif A. 1999. Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96:8573-8578.
148. Urry FM, Kushnir MM, Nelson G, McDowell M, Jennison TA. 1996. Improving ion mass ratio performance at low concentrations in methamphetamine GC-MS assay through internal standard selection. J Anal Toxicol 20:592-595.
149. Van Uytfanghe K, Stöckl D, Kaufman JM, Fiers T, Ross HA, De Leenheer AP, Thienpont LM. 2004. Evaluation of a candidate reference measurement procedure for serum free testosterone based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Chem 50:2101-2110.
150. Vicente FB, Smith FA, Sierra R, Wang S. 2006. Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry. Clin Chem Lab Med 44:70-75.
151. Wang C, Catlin D, Demers L, Starcevic B, Swerdloff RS. 2004. Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography tandem mass spectrometry. J Clin Endocrinol Metab 89:534-543.
152. Wells MJM. 2003. Principles of extraction and the extraction of semivolatile organic from liquids. In: Somenath M, editor. Sample preparation techniques in analytical chemistry. John Wiley &Sons, Inc. pp. 37-131.
153. Westgard JO, Klee GG. 2005. Quality management. In: Ashwood ER, Burtis CA, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th edition. New York: Saunders, pp. 485-532.
154. Witte DL, VanNess SA, Angstadt DS, Pennell BJ. 1997. Errors, mistakes, blunders, outliers, or unacceptable results: How many? Clin Chem 43: 1352-1356.
155. Wong T, Shackleton CH, Covey TR, Ellis G. 1992. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clin Chem 38:1830-1837.
156. Writing Group for the Women's Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. J Am. Med Assoc 288:321-333.
157. Wu N, Lippert JA, Lee ML. 2001, Practical aspects of ultrahigh pressure capillary liquid chromatography. J Chromatogr A 911:1-12.
158. Xu X, Veals J, Korfmacher WA. 2003. Comparison of conventional and enhanced mass resolution triple-quadrupole mass spectrometers for discovery bioanalytical applications. Rapid Commun Mass Spectrom 77:832-837.
159. Xu X, Keefer LK, Waterhouse DJ, Saavedra JE, Veenstra TD, Ziegler RG. 2004. Measuring seven endogenous ketoic estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 76:5829-5836.